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Stratified Care vs Stepped Care for Depression
A Cluster Randomized Clinical Trial
Jaime Delgadillo, PhD; Shehzad Ali, PhD; Kieran Fleck, PGDip; Charlotte Agnew, PGCert; Amy Southgate, MSc;
Laura Parkhouse, MSc; Zachary D. Cohen, PhD; Robert J. DeRubeis, PhD; Michael Barkham, PhD
IMPORTANCE Depression is a major cause of disability worldwide. Although empirically
supported treatments are available, there is scarce evidence on how to effectively
personalize psychological treatment selection.
OBJECTIVE To compare the clinical effectiveness and cost-effectiveness of 2 treatment
selection strategies: stepped care and stratified care.
DESIGN, SETTING, AND PARTICIPANTS Thismultisite, cluster randomized clinical trial recruited
participants from the English National Health Service from July 5, 2018, to February 1, 2019.
Thirty clinicians working across 4 psychological therapy services were randomly assigned to
provide stratified (n = 15) or stepped (n = 15) care. In stepped care, patients sequentially
access low-intensity guided self-help followed by high-intensity psychotherapy. In stratified
care, patients are matched with either low- or high-intensity treatments at initial assessment.
Data were analyzed fromMay 18, 2020, to October 13, 2021, using intention-to-treat
principles.
INTERVENTIONS All clinicians used the same interview schedule to conduct initial
assessments with patients seeking psychological treatment for commonmental disorders,
but those in the stratified care group received a personalized treatment recommendation for
each patient generated by amachine learning algorithm. Eligible patients received either
stratified or stepped care (ie, treatment as usual).
MAIN OUTCOMES ANDMEASURES The preregistered outcomewas posttreatment reliable and
clinically significant improvement (RCSI) of depression symptoms (measured using the
9-item Patient Health Questionnaire). The RCSI outcomewas compared between groups
using logistic regression adjusted for baseline severity. Cost-effectiveness analyses compared
incremental costs and health outcomes of the 2 treatment pathways.
RESULTS A total of 951 patients were included (618 women among 950with data available
[65.1%]; mean [SD] age, 38.27 [14.53] years). The proportion of cases of RCSI was
significantly higher in the stratified care arm compared with the stepped care arm (264 of
505 [52.3%] vs 134 of 297 [45.1%]; odds ratio, 1.40 [95% CI, 1.04-1.87]; P = .03). Stratified
care was associated with a higher mean additional cost per patient (£104.5 [95% CI,
£67.5-£141.6] [$139.83 (95% CI, $90.32-$189.48)]; P < .001) becausemore patients accessed
high-intensity treatments (332 of 583 [56.9%] vs 107 of 368 [29.1%]; χ2 = 70.51; P < .001),
but this additional cost resulted in an approximately 7% increase in the probability of RCSI.
CONCLUSIONS AND RELEVANCE In this cluster randomized clinical trial of adults with common
mental disorders, stratified care was efficacious and cost-effective for the treatment of
depression symptoms compared with stepped care. Stratified care can improve depression
treatment outcomes at a modest additional cost.
TRIAL REGISTRATION isrctn.org Identifier: ISRCTN11106183
JAMA Psychiatry. doi:10.1001/jamapsychiatry.2021.3539
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C
linicalguidelines for themanagementofdepressionrec-
ommend psychological interventions organized in a
steppedcaremodel, inwhichmostpatients accessonly
low-intensity treatments such as guided self-help, and pa-
tientswho remain symptomatic after this stepcanaccessmore
intensive andcostlypsychotherapies suchas cognitivebehav-
ioral therapy.1Systematic reviewsof clinical trials indicate that
steppedcare results in improvedeffect sizes (Cohend = 0.34)2
and higher odds of recovery (odds ratio [OR], 1.31 [IQR,
1.05-1.66])3 relative to usual care. In theory, stepped care is a
self-correctingmodel4 inwhichpatients eventually receive an
appropriately intensive treatment for their needs. Thismodel
widens access to care byoffering the least restrictive and least
costly interventions to most people.5
Stepped care has been implemented at a national level in
England, throughthe ImprovingAccess toPsychologicalThera-
pies (IAPT)program,whichcurrently receivesmore than 1mil-
lion referrals per year.6A systematic review of studies arising
from the IAPT program7 indicated that stepped care is gener-
ally associatedwith largepre- toposttreatment effect sizes for
depression (Cohen d = 0.87). However, these effects were at-
tenuated in subgroups of patients with more complex
presentations,7suchas thosewithcomorbidphysical illnesses,8
personality disorder traits,9 disabilities,10 and low treatment
expectancies10 and those living in socioeconomically de-
prived circumstances.11These complicating factors have a cu-
mulative effect, such that patients with several of these fea-
tures tend to have poorer treatment outcomes.10,12 On this
basis, some have argued that IAPT services should move to-
ward a stratified approach to psychological treatment selec-
tion, which would involve matching the intensity of treat-
ment to the level of complexity in each individual case.12
Stratified medicine aims to identify individuals who will
have the most clinical benefit or least harm from specific
treatments.13Recent studies10,12,14,15have indicated that strati-
fied carehaspotential to improve the effectiveness of psycho-
logical care for depression. However, most of these studies
draw their conclusions from post hoc analyses of retrospec-
tive data, and the only prospective study16 was underpow-
ered to test its primary hypothesis. Rigorous and adequately
powered experimental studies are necessary to determine
whether stratified caremaybeaneffective andaffordableway
to organize psychological interventions. To fill this evidence
gap,we conducted a cluster randomized clinical trial of strati-
fied care vs stepped care in IAPT services. We hypothesized
that stratified care would improve depression treatment out-





This pragmatic, multisite, single-blind, cluster randomized
clinical trial involved4 IAPTservices innorthernEngland that
were managed by Lancashire and South Cumbria NHS
(National Health Service) Foundation Trust and Rotherham
Doncaster and South Humber NHS Foundation Trust. These
services implemented stepped care in line with national
guidelines.1 The trial protocol (Supplement 1) was preregis-
tered and was approved by a research ethics committee and
the Health Research Authority. This study followed the
Consolidated Standards of Reporting Trials (CONSORT)
reporting guideline.
Participants
The research team recruited clinicians after presenting the
study rationale at clinical team meetings. Interested clini-
cians provided written informed consent via email. Patients
seekingpsychological treatmentwere recruitedbyparticipat-
ing clinicians using a standardized recruitment script at the
start of routine assessments that aimed todetermine suitabil-
ity for treatment in the IAPT program. Patients provided
verbal consent because assessments were conducted via
telephone.
Clinicians were included if theywere psychological well-
being practitioners who conducted initial assessments in the
participating services andwerequalifiedwithanationally rec-
ognized postgraduate certificate in low-intensity psychologi-
cal interventions (eMethods 1 in Supplement 2). Consenting
patients were eligible if they (1) sought treatment for a com-
monmentaldisorder (unipolardepression,posttraumaticstress
disorder,obsessive-compulsivedisorder,bodydysmorphicdis-
order, phobias, andother anxietydisorders); (2)weredeemed
suitable for treatment in the IAPT program according to clini-
cal guidelines; and (3) accessed treatment, definedby attend-
ing at least 1 session after their initial assessment. Regarding
the second criterion, patients deemed unsuitable for treat-
ment in this setting had severe mental disorders (eg, psy-
chotic, bipolar), severe learningdisabilities, substancedepen-
dence, acute suicidal risk, or problemsnotmeeting criteria for
a common mental disorder.17 Patients were excluded from
theseservicesand thestudy if theywerealreadyaccessingpsy-
chological treatment elsewhere (ie, privately or throughother
services). No other exclusion criteria were applied, and pa-
tients were eligible for participation regardless of their cur-
rent use of medications or other medical interventions.
Randomization andMasking
Consenting clinicians were randomized to a stratified treat-
mentgrouporasteppedcare (treatmentasusual) controlgroup
Key Points
Question Is stratified care an efficacious and cost-effective
approach to psychological treatment selection compared with
stepped care?
Findings In this cluster randomized clinical trial of 951 adults with
commonmental disorders, stratified care was efficacious and
cost-effective for the treatment of depression symptoms relative
to stepped care.
Meaning These findings suggest that stratified care has the
potential to improve depression treatment outcomes at a modest
incremental cost.
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by an independent research assistant using a computer-
generated 1:1 randomization schedule in blocks of 4, strati-
fied by team. Randomization was clustered by clinicians to
minimize contamination bias that may occur if clinicians ap-
plied stratified carewith somepatients and stepped carewith
others. Clinicians were therefore aware of their random allo-
cation, which was communicated to them after randomiza-
tion.Patientsprovided informedconsent forclinicians togather
assessment information, enter it into a computer system, and
use it to informtheir treatment recommendation,but theywere




All consenting patients were assessed by participating clini-
ciansusing thesamesemistructured interviewschedule.These
were routine telephone-based assessments that lasted an av-
erageof 40minutes and followedpractice guidelines for IAPT
services.17 The assessments covered the patient’s presenting
problems and their impact, history, current life circum-
stances, and treatment goals. As part of this assessment, cli-
nicians inbothgroupsgatheredclinical anddemographicdata
thatwere entered in a computerized application as part of the
studyprocedures.Raceandethnicitywereself-reportedbypar-
ticipants. Although they provided a self-reported category to
clinicians who undertook the assessments, this information
was aggregated in a binary variable (White British; other) by
clinical services before data were shared with the research
team. No other details about race and ethnicity were avail-
able to the research team.
Clinicians in the stratified care groupusedaversionof the
application that provided a personalized treatment recom-
mendation in real time, recommending either a low- or high-
intensity treatmentbasedoneachpatient’s features.These cli-
nicians were trained to discuss this recommendation with
patients following good practice principles of shared
decision-making18andcame toa final treatment allocationde-
cision that was recorded in the application. Clinicians in the
stepped care control group used the application only to enter
data, but they did not receive a personalized recommenda-
tion, and theyallocatedpatients to treatment followingguide-
lines for stepped care.1,17 Consistent with these guidelines,
stepped care initially allocatesmost patients to low-intensity
treatments,butpatientswithspecificdisorders (eg, social anxi-
ety disorder, posttraumatic stress disorder, body dysmorphic
disorder) and those who have severe impairment can be re-
ferred directly for high-intensity treatments.17 Treatment al-
location decisions in routine care are often made after initial
assessment interviewswithpatients and in consultationwith
supervisors or senior clinicians.
Artificial Intelligence Technology
The stratified care application used in this trial is a technol-
ogy that (1) collects data, (2) processes inputs using a ma-
chine learning algorithm, and (3) outputs apersonalized treat-
ment recommendation using automated decision rules. The
inputs for the algorithm were patient-reported measures of
depression,19 anxiety,20 functional impairment,21 personal-
ity traits,22 employment status, and race andethnicity. The al-
gorithm calculates an expected prognosis (ie, a probability of
full remissionofdepressionandanxiety symptomsafter treat-
ment) based onwhich cases are classified as standard (better
expected prognosis) or complex (poorer expected progno-
sis). Standard cases are matched with low-intensity treat-
ments, and patients later have the option to move to high-
intensity treatment if necessary, whereas complex cases are
matched directly with high-intensity treatments. The ratio-
nale is to offer more intensive treatments to patients with
higher risk of poor treatment outcomes, consistentwith prin-
ciples of stratifiedmedicine.13Further technical details about
thedata sources,machine learningapproach (LASSO [least ab-
solute shrinkage and selection operator] with optimal scal-
ing), model development, and external cross-validation are
available elsewhere.12 In addition, the stratified care applica-
tionwasprogrammed to implementdecision rules thatwould
ensure compliance with national clinical guidelines1 for the
treatment allocationof patientswith the aforementioneddis-
orders that are treated only with high-intensity psychothera-
pies in the IAPT program.17 As such, this treatment selection
approach was designed to fast-track 2 groups of patients to
high-intensity treatments:patientswithspecific conditions for
which only psychotherapy is indicated and patients whose
cases are classified as complex.
Psychological Interventions
After initial assessment interviews, patients accessed their as-
signed interventions with the first available clinician in each
service (the treating clinician was not the same person as the
assessing clinician). Low-intensity interventions are basedon
principles of cognitive behavioral therapy and involve learn-
ing coping skills with the support of a qualified psychological
well-being practitioner23 for up to 8 sessions (each lasting 30
minutes). Low-intensity interventions can be delivered as in-
dividual-guided self-help, in group settings, or as telephone-
guided computerized cognitive behavioral therapy. High-
intensity interventions are lengthier (≤20 one-hour sessions)
evidence-based psychotherapies including cognitive behav-
ioral therapy, person-centered experiential counseling for de-
pression, and eye movement desensitization and reprocess-
ing forposttraumatic stressdisorder.These interventionswere
delivered by clinicians qualified to a postgraduate level, fol-
lowing structured treatment protocols endorsed by national
guidelines,23,24 and under regular supervision (equivalent of
1 h/wk). Consistentwith thepragmatic trial design,wedidnot
record, monitor, or modify these interventions in any way to
preserve the integrityof routinelydeliveredpsychological care.
Training
All participating clinicians attended a 2-hour training course
that covered the study design, informed consent and recruit-
ment tasks, and data collection tasks. Clinicians randomized
to the stratified care groupattended 1 additional hour of train-
ing (3 hours in total), which covered the stratified care algo-
rithm, itsdecision-makingprocess, andprinciplesofgoodprac-
tice inshareddecision-making18 (discussing treatmentoptions,
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communicating recommendation,discussing rationale for rec-
ommendation, revisiting options, eliciting and addressing
questions or concerns, and codeveloping a plan).
Outcomes
Primary Outcome
The 9-item Patient Health Questionnaire (PHQ-9) is a mea-
sure of depression symptoms, where each item is rated on a
Likert scale ranging from 0 to 3 representing symptom fre-
quency in the past 2 weeks, yielding an overall severity score
ranging from 0 to 27.19 The cutoff of at least 10 is recom-
mended to screen for clinically significant depression
symptoms,19 and a change of at least 6 points is indicative of
statistically reliable change.25 Patients in the IAPT program
complete thismeasure on a session-by-session basis tomoni-
tor treatment response.6Given that treatmentduration is vari-
able in routine care, the primary end pointwas defined at the
time of each patient’s last attended treatment session.
Theprimary (preregistered) outcomeof the studywas the
proportion of patients meeting criteria for reliable and clini-
cally significant improvement (RCSI) in the PHQ-9 measure
(posttreatment scores <10 and improved by ≥6 points). Reli-
able andclinically significant improvement is a clinically strin-
gent andstatistically conservativeoutcomethatprioritizes full
remission of symptoms,26 which is important in the context
of stepped care, because patients who do not attain sympto-
matic remission have the opportunity to access further inter-
ventions to attain the best possible outcome. This outcome is
consistent with the stratified care algorithm, which was spe-
cifically trained to calculate a prognosis (probability of RCSI)
using this definition, andwhichwas expected to result in bet-
ter depression (PHQ-9) but not anxiety (Generalized Anxiety
Disorder [GAD-7]) treatment outcomes based on prior
evidence.12
Secondary Outcomes
We compared between-group differences in a range of sec-
ondary outcomes of interest. Reliable and clinically signifi-
cant improvement status in the GAD-720was examined. Fur-
thermore, IAPT services use an outcome definition termed
reliable recovery, which is a stringent outcomedefinition that
requirespatients tohaveachievedRCSI inboth thePHQ-9and
GAD-7measures.17Additional comparisonsexamined thepro-
portionsofpatientswhoaccessed low-vshigh-intensity treat-
ments, treatment duration (number of sessions), and treat-
ment dropout (defined as unilateral discontinuation of
treatment before the planned end of treatment). Adherence
to the experimental intervention was measured by compar-
ing thepercentageofagreementand interrater reliability (κ sta-
tistic) in the stratified care model–recommended vs actual
treatment selection decisions.
Statistical Analysis
Data were analyzed from May 18, 2020, to October 13, 2021.
All analyses followed intention-to-treat principles, andmiss-
ing (n = 38)posttreatmentPHQ-9and/orGAD-7scoreswere im-
putedwith an expectationmaximizationmethod using base-
line features as predictors. Data analysis was conducted in 5
steps. First, the proportion of patientswith posttreatment re-
mission (RCSI) of depression symptoms (PHQ-9) was com-
pared between groups using logistic regression adjusted for
baseline PHQ-9 scores. A mixed model (clustering by assess-
ing clinician)was estimated first, showingno significant clus-
ter effects (P = .11), so subsequent models applied a parsimo-
nious logistic regression that improved goodness of fit (−2 log
likelihood ratio test, 3262.44 [df = 1]; P < .001). A full output
of themodel-buildingprocess andgoodness-of-fit indices can
be found in eMethods 3 in Supplement 2. Second, logistic re-
gressions were repeated in the subsamples of standard and
complex cases. Third, these analyseswere repeatedusing the
anxiety (GAD-7) outcome measure and IAPT reliable recov-
eryoutcomedefinitions. Fourth,we comparedadditional sec-
ondary outcomes between groups using the χ2 and Mann-
Whitney U tests. Fifth, an economic analysis evaluated the
relative cost-effectiveness of stratified vs stepped care froma
health services perspective using a cost-effectiveness accept-
ability curve toaid interpretation.Furtherdetails about sample
size calculation and economic analyses are provided in
eMethods 2 and 4, respectively, in Supplement 2. Two-sided
P < .05 indicated statistical significance.
Results
TheCONSORTdiagram ispresented inFigure 1. Thirty-twocli-
nicianswere recruited from July 5 to October 4, 2018; 2with-
drew before the start of the trial, and 30 were randomly allo-
cated to the stratified care group (n = 15) or a stepped care
Figure 1. CONSORTDiagram
32 Eligible clinicians who provided consent
2 Clinicians excluded
1 Unable to attend training date
1 Left service before trial start
date
30 Clinicians randomized
15 Trial site 1
15 Trial site 2
583 Analyzed patient records
78 Cases with subclinical PHQ-9
scores excluded from primary
end point analysis
368 Analyzed patient records
71 Cases with subclinical PHQ-9
scores excluded from primary
end point analysis
15 Clinicians allocated to stratified
care












IAPT indicates Improving Access to Psychological Therapies; PHQ-9, 9-item
Patient Health Questionnaire.
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control group (n = 15). Clinicians in both groups had the same
qualifications andaverageweekly timeavailability for assess-
ment tasks. Overall, 1453 patients were screened from Au-
gust 20, 2018, to February 1, 2019, of whom 951 met eligibil-
ity criteria (583 in the stratified care group and 368 controls;
618women[65.1%]and332men [34.9%]among950withdata
available;mean [SD] age, 38.27 [14.53] years). A small propor-
tionofpatients (149 [15.7%])whodidnot score above the clini-
cal cutoff in thePHQ-9were excluded fromtheprimary analy-
sis (focusingon remissionof clinically significant symptoms),
but they were included in secondary analyses. Similarly, pa-
tientswhodidnot score above the clinical cutoff in theGAD-7
measure (86 [9.0%]) were excluded from that specific analy-
sis, but they were included in other secondary analyses. De-
tailed sample characteristics are presented inTable 1. In total,
225of951patients (23.7%)were classifiedby the stratifiedcare
algorithm as complex cases.
Table 2 summarizes the results of primary and secondary
outcomes. Overall, in the full sample, patients in the strati-
fied care group had significantly better depression (PHQ-9)
treatment outcomes (RCSI: 264 of 505 [52.3%] vs 134 of 297
[45.1%]; OR, 1.40 [95%CI, 1.04-1.87]; P = .03). Patients in the
stratifiedcaregroupwerealso significantlymore likely tomeet
criteria for IAPT reliable recovery (276 of 573 [48.2%]) after
treatment compared with patients in the stepped care group
(152 of 348 [43.7%];OR, 1.33 [95%CI, 1.01-1.75];P = .04). Sub-
groupanalyses indicated thatbetween-groupdifferences inde-
pression outcomes were not significant in the subsample of
complex cases (RCSI: 63 of 160 [39.4%] vs 22 of 65 [33.8%];
OR, 1.28 [95% CI, 0.70-2.35]; P = .42), but they were signifi-
cant in the subsample of standard cases (RCSI: 201 of 345
[58.3%] vs 112 of 232 [48.3%]; OR, 1.50 [95% CI, 1.07-2.09];
P = .02). Between-group comparisons in the anxiety out-
come measure were not statistically significant (eg,
Table 1. Patient Characteristics
Characteristic
Treatment groupa
Full sample (n = 951) Stratified care (n = 583) Stepped care (n = 368)
Demographics
Age, mean (SD), y 38.27 (14.53) 38.66 (14.61) 37.65 (14.41)
Sex
Female 618/950 (65.1) 378/582 (64.9) 240/368 (65.2)
Male 332/950 (34.9) 204/582 (35.1) 128/368 (34.8)
Race and ethnicityb
White 906/951 (95.3) 552/583 (94.7) 354/368 (96.2)
Other 45/951 (4.7) 31/583 (5.3) 14/368 (3.8)
Unemployed 187/951 (19.7) 131/583 (22.5) 56/368 (15.2)
Clinical features
Primary diagnosisc
Affective disorder 483/916 (52.7) 303/565 (53.6) 180/351 (51.3)
PTSD 27/916 (2.9) 16/565 (2.8) 11/351 (3.1)
OCD 14/916 (1.5) 6/565 (1.1) 8/351 (2.3)
Anxiety disorder 392/916 (42.8) 240/565 (42.5) 152/351 (43.3)
Prescribed pharmacotherapy 537/924 (58.1) 341/562 (60.7) 196/362 (54.1)
Comorbid long-term medical illnesses 182/932 (19.5) 100/574 (17.4) 82/358 (22.9)
Disability 103/921 (11.2) 61/572 (10.7) 42/349 (12.0)
SAPAS score, mean (SD)d 3.97 (1.43) 4.15 (1.44) 3.70 (1.37)
Complex cases 225/951 (23.7) 160/583 (27.4) 65/368 (17.7)
Baseline score, mean (SD)
PHQ-9e 15.47 (5.86) 16.06 (5.69) 14.54 (6.01)
GAD-7f 14.21 (4.65) 14.57 (4.54) 13.64 (4.76)
WSASg 20.33 (9.31) 21.24 (9.22) 18.96 (9.27)
Abbreviations: GAD-7, Generalized Anxiety Disorder questionnaire;
OCD, obsessive-compulsive disorder; PHQ-9, 9-item Patient Health
Questionnaire; PTSD, posttraumatic stress disorder; SAPAS, Standardised
Assessment of Personality–Abbreviated Scale; WSAS, Work and Social
Adjustment Scale.
a Unless otherwise indicated, data are expressed as number/total number (%)
of patients.
b Information on race and ethnicity was self-reported by participants but
aggregated in a binary variable (White British; other) by clinical services before
data were shared with the research team. No other details about race and
ethnicity were available to the research team.
c Primary diagnosis was determined using a semistructured interview
supplemented by validated case-findingmeasures for depression (PHQ-9) and
anxiety disorders (GAD-7). Cases with missing data in each feature were
excluded listwise.
dScores range from0 to 8, with higher scores indicating more personality
disorder traits.
e Scores range from0 to 27, with higher scores indicating more severe
depression symptoms.
f Scores range from0 to 21, with higher scores indicating more severe anxiety
symptoms.
g Scores range from0 to 40, with higher scores indicating greater impairment
to work and social functioning.
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full-sampleRCSI, 266of 538 [49.4%]vs 151of 327 [46.2%];OR,
1.19 [95% CI, 0.90-1.57]; P = .22).
Stratified carewas associatedwith a highermedian num-
ber of treatment sessions (6 [IQR, 3-9]; range, 1-30) com-
pared with stepped care (5 [IQR, 3-8]; range, 1-25) (Mann-
Whitney U test, 121106.00 [SE, 4098.98]; P < .001). This is
explained by the higher proportion of patients who accessed
high-intensity interventions in stratified care (332 of 583
[56.9%] vs 107 of 368 [29.1%]; χ2 = 70.51; P < .001), because
dropout rates were not significantly different (166 of 542
[30.6%] vs 107 of 348 [30.7%]; χ2 = 0.001; P = .97), but re-
sulted in an approximately 7% increase in the probability of
RCSI. Adherence to the stratified care model was high in the
experimental group (κ = 0.81) and significantlydifferent from
the treatment selectiondecisionsobserved in the steppedcare
group,which had low concordancewith the stratified care al-
gorithm(κ = 0.22).As illustrated inFigure2, the stratified care
pathway allocated only half of patients (297 of 583 [50.9%])
to low-intensity treatments,whereasmostof thepatients (289
of 368 [78.5%]) were initially allocated to low-intensity treat-
ments in the stepped care group.
The estimated incremental cost of stratified care was
£104.5 (95% CI, £67.5-£141.6) per patient ($139.83 [95% CI,
$90.32-$189.48] per patient) (P < .001). The cost-
effectiveness acceptability curve in Figure 3 shows that the
probability of stratified care being cost-effective, compared
with stepped care, is 50% when the willingness-to-pay
threshold per additional case of reliable improvement is
£1320 ($1766.31). The probability of stratified care being
cost-ef fec t ive inc reases to 80% and 90% for the
willingness-to-pay values of £2100 ($2810.03) and £3050
($4081.24), respectively. Further details of the economic
analysis are available in eMethods 4 and eFigures 1 and 2 in
Supplement 2.










LIT 251/583 (43.1) 261/368 (70.9)
χ2 = 70.51
<.001
HITc 332/583 (56.9) 107/368 (29.1)
Treatment sessions,
mean (SD)




Treatment dropout 166/542 (30.6) 107/348 (30.7) χ2 = 0.001 .97
Adherence to the
stratified care model
523/583 (89.7) 233/368 (63.3) χ2 = 96.41 <.001
κ Statistic 0.81 0.22 NA NA
Treatment outcomes
PHQ-9 depression RCSI
Full sample 264/505 (52.3) 134/297 (45.1) 1.40 (1.04-1.87) .03
Complex cases
subsample
63/160 (39.4) 22/65 (33.8) 1.28 (0.70-2.35) .42
Standard cases
subsample
201/345 (58.3) 112/232 (48.3) 1.50 (1.07-2.09) .02
GAD-7 anxiety RCSI
Full sample 266/538 (49.4) 151/327 (46.2) 1.19 (0.90-1.57) .22
Complex cases
subsample
52/160 (32.5) 21/65 (32.3) 1.02 (0.55-1.89) .96
Standard cases
subsample
214/378 (56.6) 130/262 (49.6) 1.35 (0.98-1.85) .07
IAPT reliable recovery,
full sampled




IAPT, Improving Access to
Psychological Therapies;
LIT, low-intensity treatments;
PHQ-9, 9-item Patient Health
Questionnaire; RCSI, reliable and
clinically significant improvement.
a Unless otherwise indicated, data are
expressed as number/total number
(%) of patients.
bUnless otherwise indicated, data are
expressed as odds ratio (95% CI).
c Of these, 46 (13.9%) had prior LIT in
the stratified care group and 28
(7.6%) had prior LIT in the stepped
care group.
dRequires patients with case-level
PHQ-9 and/or GAD-7 symptoms to
have (1) attained statistically reliable
improvement on case-level
measures, (2) to have subclinical
symptoms on bothmeasures after
treatment, and (3) to not have
statistically reliable deterioration on
any of thesemeasures after
treatment.







583 Stratified care 
Mean treatment cost: £248.48
Probability of full remission of
depression symptoms: 52.3%
368 Stepped care
Mean treatment cost: £146.45
Probability of full remission of
depression symptoms: 45.1%
286 (49.1%) 79 (21.5%)
46 Stepped up
(15.5% of LIT cases)
28 Stepped up





To convert costs to US dollars,
multiply pounds sterling by 1.338.
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Discussion
Agrowingliterature inthefieldofdepressionsuggests that treat-
mentoutcomescouldbe improved throughpersonalized treat-
mentselection.27Thefindingsof this trial indicate thatstratified
careimprovesdepressionoutcomes,albeitatanincrementalcost
per treatment.This improvementcomeswithnoeffectondrop-
out rates,despite the fact that significantlymorepatients in the
stratifiedcaregroupaccessedhigh-intensity treatments,which
have longerwaiting lists.Dropout rates in thepresentstudyand
acrossbothtrialarms(approximately 30%)wereconsistentwith
datafromIAPTservices.7Furthermore, thestratifiedcaremodel
was feasible to implement and had a high adherence rate
(κ= 0.81).Treatmentselectiondecisionsmadeinthesteppedcare
group had nearly chance-level convergence with those in the
stratified care algorithm (κ= 0.22), indicating that decision-
makingacross thesemodels ishighlydistinctive. Stratifiedcare
also increased theefficiencyof initial assessments, becausecli-




ity for available treatments,which is commonplace in stepped
care.23
As expected, the proportions of patients with full remis-
sion (RCSI) of depression and anxiety symptoms were higher
in stratified care compared with stepped care, but differences
were statistically significant only in the PHQ-9 measure. This
is consistentwithprior evidence suggesting that stratified care
could improveremissionrates inthePHQ-9butnot intheGAD-7
measure.12 A plausible explanation is that there was little dif-
ference in the treatmentallocationofpatientswithanxietydis-
ordersbetweenstratifiedandsteppedcare, becausebothmod-
els referpatientswithsomeconditions (eg,posttraumatic stress
disorder)directly tohigh-intensity treatments in linewithclini-
cal guidelines.1,17 These results are consistent with prior evi-
dence that IAPT services that have a higher proportion of pa-
tients accessing high-intensity treatments tend to have better
treatment outcomes.17,25 Related to this point, a possible ex-
planation for the observed effect may be owing to an absolute
increase in the proportion of patients allocated to high-
intensity treatment, rather than a strategic matching effect.
Future implementation trials could examine whether the ef-
fect of stratified treatment selection varies across IAPT ser-
vices, with variable proportions of patients allocated to high-
intensity treatment.
Contrary to our expectations, only standard (ie, less com-
plex) caseshad significantly better outcomes in stratified care.
In thepresent study, relatively fewpatientswith thepoorestex-
pected prognosis were classified as complex cases (225 of 951
[23.7%]), and it may be that the observed trend toward better
outcomes in stratified care for the complex cases could be di-
luted by the inclusion of some patients with chronic condi-
tions that simply do not respond to interventions available in
IAPT services. Previous research28 suggests that the presence
ofpatientswithchronic conditions inaclinical samplemayob-
scure the differential treatment response in those with more
treatable conditions. It is, of course,possible that stratifiedcare
does not work for complex cases as defined in this study, and
future research should consider how to improve outcomes for
those at the highest risk of poor treatment response.
Limitations
The pragmatic trial designmaximized feasibility, sample size,
andexternal validity to the routinecare context, but inevitably
had someweaknesses in terms of internal validity. Outcomes
were patient reported, and no formal diagnostic interviews or
observer-rated outcomes were available. The sole reliance on
patient-reportedmeasuresmeans thatwecannot ruleoutorex-
amine the potential influence of biases such as motivated re-
sponding and social desirability bias. Although thePHQ-9and
GAD-7measuresare relevant to thebroadrangeofaffectiveand
anxiety symptoms reportedbyparticipants, a significant limi-




ings to other racial and ethnicminority groups. Furthermore,
outcomesweredefinedat the last attended treatment session,
andthereforethemaintenanceoftheseeffectsovera longertime
framecouldnotbeestablished.A further implication is that, on
average,thefinaloutcomesinthestratifiedcaregroupweremea-
sured at a later time comparedwith those in stepped care, be-
causemorepatientshad lengthierhigh-intensity treatments in
the experimental group. Thus, there are uncertainties related
tothepragmaticdesign,andfuturestudiescouldestablishafixed
follow-up measurement schedule to understand short- and
longer-termeffectswithgreaterprecision.Theeconomicanaly-
sis was limited to a comparative examination of acute-phase
treatment costs, butwider outcomes such as quality-adjusted
life-years anduse of health services after the endof treatment
remain unknown.
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Probability of stratified care being cost-effective (vs stepped care) is greater
than 50% if the willingness-to-pay (WTP) threshold is greater than £1320
($1766.31) per additional case of reliable improvement (dashed lines).
GBP indicates pound sterling currency.
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Conclusions
Overall, the present findings indicate that stratified care is
feasible to implement in routine IAPT services, improving
the efficiency and precision of psychological assessments
in a way that preserves shared decision-making. Imple-
mentation of stratified care resulted in better depression
treatment outcomes albeit with an additional cost per treat-
ment.
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